Type 2 diabetes trials in Lithuania
1 trial · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Alytus, Kaunas, Klaipeda, Kovno, Vilnius
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473EU 2025-521188-11-00Registry updated 2026-10-28
All Type 2 diabetes trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.